(Total Views: 512)
Posted On: 05/28/2025 2:50:13 PM
Post# of 154581
Nothing suggesting anything of interest to this message board. GLAL LTL
British drugmaker GSK is preparing for potential new U.S. tariffs on its medicines and can handle the challenge, the company’s leader said Wednesday.
“I would say we’ve been preparing, we have what it will take to navigate and mitigate,” GSK Chief Executive Emma Walmsley said at our Future of Everything conference in New York. “It will take some actions but I think we have that in hand and we’ll just respond as the data comes through.”
“Supply chains in pharmaceuticals are extremely complex because of raw materials as well as fill and finish, but I think we have what will be required to respond, and we don’t have manufacturing in China,” she said.
British drugmaker GSK is preparing for potential new U.S. tariffs on its medicines and can handle the challenge, the company’s leader said Wednesday.
“I would say we’ve been preparing, we have what it will take to navigate and mitigate,” GSK Chief Executive Emma Walmsley said at our Future of Everything conference in New York. “It will take some actions but I think we have that in hand and we’ll just respond as the data comes through.”
“Supply chains in pharmaceuticals are extremely complex because of raw materials as well as fill and finish, but I think we have what will be required to respond, and we don’t have manufacturing in China,” she said.

